To: | Arena Pharmaceuticals, Inc. (ricketts-docket@fzlz.com) |
Subject: | U.S. Trademark Application Serial No. 88491734 - VELSIPITY - ARPI 1908455 |
Sent: | March 18, 2020 09:13:11 AM |
Sent As: | ecom124@uspto.gov |
Attachments: |
United States Patent and Trademark Office (USPTO)
Office Action (Official Letter) About Applicant’s Trademark Application
U.S. Application Serial No. 88491734
Mark: VELSIPITY
|
|
Correspondence Address: FROSS ZELNICK LEHRMAN & ZISSU, P.C. |
|
Applicant: Arena Pharmaceuticals, Inc.
|
|
Reference/Docket No. ARPI 1908455
Correspondence Email Address: |
|
EXAMINER’S AMENDMENT
Issue date: March 18, 2020
USPTO database searched; no conflicting marks found. The trademark examining attorney searched the USPTO database of registered and pending marks and found no conflicting marks that would bar registration under Trademark Act Section 2(d). 15 U.S.C. §1052(d); TMEP §704.02.
Application has been amended as shown below. As agreed to by Michael Antoniccui on March 17, 2020, the examining attorney has amended the application as shown below. Please notify the examining attorney immediately of any objections. TMEP §707. Otherwise, no response is required. Id. In addition, applicant is advised that amendments to the goods and/or services are permitted only if they clarify or limit them; amendments that add to or broaden the scope of the goods and/or services are not permitted. 37 C.F.R. §2.71(a).
The identification of goods is amended to read as follows:
- International Class 5: Pharmaceutical preparations for human use to treat ulcerative colitis, diseases and disorders of the gastrointestinal tract, Crohn's disease, irritable bowel syndrome, autoimmune diseases and dermatological diseases and disorders
See TMEP §§1402.01, 1402.01(e).
If applicant has questions regarding this Examiner's Amendment, please telephone or e-mail the assigned trademark examining attorney.
/Tara L. Bhupathi/
Examining Attorney
Law Office 124
(571) 272-5557
tara.bhupathi@uspto.gov